JP Morgan Chase’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $5.37M | Buy |
|
|||||
|
2023
Q2 | $329K | Sell |
|
|||||
|
2023
Q1 | $2.63M | Sell |
|
|||||
|
2022
Q4 | $4.91M | Buy |
|
|||||
|
2022
Q3 | $2.42M | Sell |
|
|||||
|
2022
Q2 | $4.49M | Buy |
|
|||||
|
2022
Q1 | $4.97M | Buy |
|
|||||
|
2021
Q4 | $2.99M | Sell |
|
|||||
|
2021
Q3 | $2.94M | Sell |
|
|||||
|
2021
Q2 | $22.1M | Buy |
|
|||||
|
2021
Q1 | $22.3M | Sell |
|
|||||
|
2020
Q4 | $32.6M | Buy |
|
|||||
|
2020
Q3 | $52.4M | Sell |
|
|||||
|
2020
Q2 | $75.6M | Buy |
|
|||||
|
2020
Q1 | $92.5M | Sell |
|
|||||
|
2019
Q4 | $189M | Buy |
|
|||||
|
2019
Q3 | $97.2M | Buy |
|
|||||
|
2019
Q2 | $102M | Buy |
|
|||||
|
2019
Q1 | $83.8M | Sell |
|
|||||
|
2018
Q4 | $125M | Buy |
|
|||||
|
2018
Q3 | $151M | Sell |
|
|||||
|
2018
Q2 | $107M | Sell |
|
|||||
|
2018
Q1 | $101M | Sell |
|
|||||
|
2017
Q4 | $113M | Buy |
|
|||||
|
2017
Q3 | $51.4M | Buy |
|
|||||
|
2017
Q2 | $61M | Sell |
|
|||||
|
2017
Q1 | $98M | Buy |
|
|||||
|
2016
Q4 | $92M | Buy |
|
|||||
|
2016
Q3 | $137M | Buy |
|
|||||
|
2016
Q2 | $118M | Buy |
|
|||||
|
2016
Q1 | $42.2M | Buy |
|
|||||
|
2015
Q4 | $47.2M | Buy |
|
|||||
|
2015
Q3 | $50.7M | Buy |
|
|||||
|
2015
Q2 | $70.4M | Buy |
|
|||||
|
2015
Q1 | $77.4M | Buy |
|
|||||
|
2014
Q4 | $8.55M | Buy |
|
|||||
|
2014
Q3 | $3.69M | Buy |
|
|||||
|
2014
Q2 | $2.38M | Sell |
|
|||||
|
2014
Q1 | $16.1M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $4.76M | Buy |
|